305 related articles for article (PubMed ID: 17646841)
1. Ideal body weight correlates better with engraftment after PBSC autograft than actual body weight, but is under-estimated in myeloma patients possibly due to disease-related height loss.
Maclean PS; Parker AN; McQuaker IG; Clark AD; Farrell E; Douglas KW
Bone Marrow Transplant; 2007 Oct; 40(7):665-9. PubMed ID: 17646841
[TBL] [Abstract][Full Text] [Related]
2. Comparison of autologous peripheral blood stem cell dosing by ideal vs actual body weight.
Waples JM; Moreb JS; Sugrue M; Belanger G; Kubilis P; Lynch JW; Gian V; Weeks F; Wingard J
Bone Marrow Transplant; 1999 May; 23(9):867-73. PubMed ID: 10338040
[TBL] [Abstract][Full Text] [Related]
3. Ideal or actual body weight to calculate CD34+ cell doses for allogeneic hematopoietic stem cell transplantation?
Cilley J; Rihn C; Monreal J; Gordon LI; Singhal S; Tallman M; Williams S; Winter J; Mehta J
Bone Marrow Transplant; 2004 Jan; 33(2):161-4. PubMed ID: 14647242
[TBL] [Abstract][Full Text] [Related]
4. Ideal or actual body weight to calculate CD34+ cell doses for autologous hematopoietic stem cell transplantation?
Ali MY; Oyama Y; Monreal J; Winter JN; Tallman MS; Williams SF; Singhal S; Gordon LI; Mehta J
Bone Marrow Transplant; 2003 May; 31(10):861-4. PubMed ID: 12748662
[TBL] [Abstract][Full Text] [Related]
5. Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma.
Wallington-Beddoe CT; Gottlieb DJ; Garvin F; Antonenas V; Sartor MM
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1386-93. PubMed ID: 19822297
[TBL] [Abstract][Full Text] [Related]
6. The use of adjusted ideal body weight for overweight patients undergoing HPC mobilisation for autologous transplantation.
Hicks C; Trickett A; Kwan YL; Ramanathan S
Ann Hematol; 2012 Nov; 91(11):1795-801. PubMed ID: 22836946
[TBL] [Abstract][Full Text] [Related]
7. Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantation.
Singhal S; Gordon LI; Tallman MS; Winter JN; Evens AM; Frankfurt O; Williams SF; Grinblatt D; Kaminer L; Meagher R; Mehta J
Bone Marrow Transplant; 2006 Mar; 37(6):553-7. PubMed ID: 16444282
[TBL] [Abstract][Full Text] [Related]
8. Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
Klaus J; Herrmann D; Breitkreutz I; Hegenbart U; Mazitschek U; Egerer G; Cremer FW; Lowenthal RM; Huesing J; Fruehauf S; Moehler T; Ho AD; Goldschmidt H
Eur J Haematol; 2007 Jan; 78(1):21-8. PubMed ID: 17042762
[TBL] [Abstract][Full Text] [Related]
9. CXCR4 expression on transplanted peripheral blood CD34+ cells: relationship to engraftment after autologous transplantation in a cohort of multiple myeloma patients.
Hicks C; Isaacs A; Wong R; Chong BH
Ann Hematol; 2011 May; 90(5):547-55. PubMed ID: 20957366
[TBL] [Abstract][Full Text] [Related]
10. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
Wang S; Nademanee A; Qian D; Dagis A; Park HS; Fridey J; Smith E; Snyder D; Somlo G; Stein A; Rosenthal J; Falk P; Kogut N; Palmer J; Gaal K; Kim Y; Bhatia R; Yuan S; Kay C; Weiss L; Forman S
Transfusion; 2007 Dec; 47(12):2207-16. PubMed ID: 17714420
[TBL] [Abstract][Full Text] [Related]
11. Role of the CD34+ 38- cells in posttransplant hematopoietic recovery.
Hénon P; Sovalat H; Bourderont D; Ojeda-Uribe M; Arkam Y; Wunder E; Raidot JP; Husseini F; Audhuy B
Stem Cells; 1998; 16 Suppl 1():113-22. PubMed ID: 11012153
[TBL] [Abstract][Full Text] [Related]
12. Actual or ideal body weight to calculate CD34+ cell dose in patients undergoing autologous hematopoietic SCT for myeloma?
Singh V; Krishnamurthy J; Duffey S; Meagher R; Villa M; Monreal J; Evens A; Frankfurt O; Altman J; Gordon L; Tallman M; Williams S; Winter J; Singhal S; Mehta J
Bone Marrow Transplant; 2009 Feb; 43(4):301-5. PubMed ID: 18836491
[TBL] [Abstract][Full Text] [Related]
13. How to calculate the quantity of CD34+ cells infused? A single center cohort study based on actual, ideal or adjusted ideal body weight.
Topcuoglu P; Akcaglayan Soydan E; Ekiz F; Ayyildiz E; Dalva K; Ozcan M; Arslan O; Arat M; Ilhan O
Transfus Apher Sci; 2007 Jun; 36(3):275-80. PubMed ID: 17569588
[TBL] [Abstract][Full Text] [Related]
14. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma.
Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP
Biol Blood Marrow Transplant; 2008 Jan; 14(1):116-24. PubMed ID: 18158968
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors for hematopoietic engraftment after autologous peripheral blood stem cell transplantation for AL amyloidosis.
Oran B; Malek K; Sanchorawala V; Wright DG; Quillen K; Finn KT; La Valley M; Skinner M; Seldin DC
Bone Marrow Transplant; 2005 Mar; 35(6):567-75. PubMed ID: 15665842
[TBL] [Abstract][Full Text] [Related]
16. Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation.
Ataergin S; Arpaci F; Turan M; Solchaga L; Cetin T; Ozturk M; Ozet A; Komurcu S; Ozturk B
Am J Hematol; 2008 Aug; 83(8):644-8. PubMed ID: 18508321
[TBL] [Abstract][Full Text] [Related]
17. Post-thaw viable CD34(+) cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation.
Lee S; Kim S; Kim H; Baek EJ; Jin H; Kim J; Kim HO
Vox Sang; 2008 Feb; 94(2):146-52. PubMed ID: 18028260
[TBL] [Abstract][Full Text] [Related]
18. Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilization.
Sinitsyn Y; Malone A; Mandeli J; Grosskreutz C; Osman K; Scigliano E; Shi P; Isola L
Cytotherapy; 2009; 11(4):457-63. PubMed ID: 19499401
[TBL] [Abstract][Full Text] [Related]
19. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
20. A comparison of CD34+ cell selected and unselected autologous peripheral blood stem cell transplantation for multiple myeloma: a case controlled analysis.
Gandhi M; Jestice H; Scott M; Bloxham D; Bass G; Craig J; Marcus R
Bone Marrow Transplant; 1999 Aug; 24(4):369-75. PubMed ID: 10467325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
